Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019006

Chief Executive Officer gave up 2,941 shares (to pay taxes)

  • Chief Executive Officer acquired 62,440 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hardy Alexander · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-13 Shares withheld for taxes : show line 1 in the form −2,941 $58.51 $172,078 156,447 D
2026-03-16 Grant or award : show line 2 in the form +62,440 218,887 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-16 Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) +89,200 89,200 D
Loading xslF345X05/wk-form4_1773794583.xml…